Evidence map›Paper›PMID 34787071›Full record

ArticleBioengineered2022

Interference of KLF9 relieved the development of gestational diabetes mellitus by upregulating DDAH2.

Weixia Chen, Huiqin Wang, Jing Liu, Kaixia Li

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Weixia ChenDepartments of Clinical Laboratory, Zaozhuang Municipal Hospital, Zaozhuang, Shandong, China.
Huiqin WangDepartments of Clinical Laboratory, Zaozhuang Municipal Hospital, Zaozhuang, Shandong, China.
Jing LiuDepartments of Clinical Laboratory, Zaozhuang Municipal Hospital, Zaozhuang, Shandong, China.
Kaixia LiDepartment of Obstetrics, Huai'an Maternal and Child Health Hospital, Huai'an, Jiangsu, China.
Zaozhuang Municipal Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is a situation where glucose intolerance is found in pregnant women without a previous diagnosis of diabetes. The role of Kruppel-like factor 9 (KLF9) has not been investigated in GDM, which constituted the aim of our study. HTR8/SVneo cells were induced by high glucose (HG) and pregnant mice were treated with streptozocin (STZ) to establish GDM model

Indexed as

Up-RegulationAmidohydrolasesAnimalsCell LineCell SurvivalDiabetes, GestationalDisease Models, AnimalFemaleGlucoseHumansKruppel-Like Transcription FactorsMiceOxidative StressPregnancyStreptozocinTrophoblastsAmidohydrolasesdimethylargininaseGlucoseKLF9 protein, humanKruppel-Like Transcription FactorsStreptozocinDDAH2gestational diabetes mellitusinflammationKLF9

Identifiers

PMID34787071
PMCPMC8805879
OpenAlexW3213009145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.